Your browser doesn't support javascript.
loading
The Effect of IFN-ß Treatment on Plasma Levels of BDNF and IL-6 in Relapsing-Remitting Multiple Sclerosis Patients.
Shajarian, Mansour; Alsahebfosoul, Fereshteh; Etemadifar, Masoud.
Affiliation
  • Shajarian M; Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Alsahebfosoul F; Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Etemadifar M; Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Neuroimmunomodulation ; 28(3): 150-157, 2021.
Article in En | MEDLINE | ID: mdl-34182566
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Prognostic_studies Limits: Humans Language: En Journal: Neuroimmunomodulation Journal subject: ALERGIA E IMUNOLOGIA / NEUROLOGIA Year: 2021 Type: Article Affiliation country: Iran
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Prognostic_studies Limits: Humans Language: En Journal: Neuroimmunomodulation Journal subject: ALERGIA E IMUNOLOGIA / NEUROLOGIA Year: 2021 Type: Article Affiliation country: Iran